APR 10, 2020 8:54 PM PDT

Cancer Therapy Drug Reverses Kidney Damage

WRITTEN BY: Nouran Amin

According to a study published in the journal Science Translational Medicine, a therapeutic previously used for cancer therapy has shown promising effects on reversing kidney damage in patients with systemic lupus erythematosus (SLE, or lupus).

Learn more about SLE:

"Kidney damage affects about half of the patients with lupus, sometimes leading to renal failure with a requirement for dialysis or transplantation," said Joe Craft, the Paul B. Beeson Professor of Medicine (rheumatology) and professor of immunobiology at Yale University. "Finding what causes that damage is extremely important."

SLE is an autoimmune disease caused by the individual’s immune cells attack their own tissues and kidneys can be particularly susceptible to the disease pathology resulting in lupus nephritis.

For lupus nephritis, a cell population referred to as ‘T-cells’ colonize kidney tissue triggering a decrease in oxygen and leading to tissue damage, potentially end-stage kidney disease. When researchers investigated the effects on infiltrating T-cells, they found that the T-cells express a marker known as hypoxia-inducible factor-1 (HIF-1) that is dependent on oxygen levels in the kidney. Activating HIF-1, results in the T-cells attacking the kidney tissues and furthering causing destruction of kidney function.

These findings allowed investigators to hypothesize that inhibiting HIF-1 function might increase oxygen levels and reduce the impact on kidneys. Thus, researchers used the HIF-1 blocking drug previously utilized in cancer therapy on mouse models of lupus.

"The findings suggest this therapy might be beneficial in lupus nephritis," Craft said. "Since this drug and others that block HIF-1 function have been used in humans with cancer, they could be used for treatment of patients with lupus."

Source: Science Daily

 

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
NOV 02, 2020
Cancer
Using an Anti-Malarial Drug to Fight Cancer
NOV 02, 2020
Using an Anti-Malarial Drug to Fight Cancer
Modern pharmaceutical companies spend billions of dollars and years of time developing the next big drug. What if they d ...
NOV 23, 2020
Drug Discovery & Development
Therapeutically Active Ion-Channels
NOV 23, 2020
Therapeutically Active Ion-Channels
Therapeutically relevant ion channels have inspired researchers to look into drugs that can regulate their activity. Ion ...
DEC 01, 2020
Drug Discovery & Development
Breakthrough Drug Reduces Inflammation and Pain in Arthritis
DEC 01, 2020
Breakthrough Drug Reduces Inflammation and Pain in Arthritis
Researchers from the Universities of Oxford and Birmingham in the UK have found that otilimab can reduce infla ...
DEC 28, 2020
Drug Discovery & Development
Anti-Diarrhea Drug Kills Aggressive Brain Cancer Cells
DEC 28, 2020
Anti-Diarrhea Drug Kills Aggressive Brain Cancer Cells
Glioblastoma is a very aggressive and lethal form of brain cancer that responds poorly to chemotherapy in children and a ...
DEC 30, 2020
Drug Discovery & Development
Llama Antibody Prevents Infection by COVID-19
DEC 30, 2020
Llama Antibody Prevents Infection by COVID-19
There's more to llamas than being livestock and hilarious companion animals. They also harbor an immune system capab ...
JAN 05, 2021
Drug Discovery & Development
Promising Epigenetic Treatment for Depression Works After One Dose
JAN 05, 2021
Promising Epigenetic Treatment for Depression Works After One Dose
Researchers affiliated with the University of Sao Paulo in Brazil have used epigenetic modulators to reduce stress-induc ...
Loading Comments...